References
- Royal College of Obstetricians and Gynaecologists. The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage [Guideline no. 17]. London, UK; 2011
- Indonesian Obstetric and Gynecological Society (HIFERI-POGI). Methodological guidelines for recurrent miscarriage. Jakarta; 2011
- Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). Progesterone support of the luteal phase and the first trimester. 2013. Available from: http://www.ranzcog.edu.au/doc/progesterone-support-of-the-luteal-phase-and-early-pregnancy.html
- Practice Committee of American Society of Reproductive Medicine (ASRM). Definition of infertility and recurrent pregnancy loss. Fertil Steril 2013;99:63
- National Institute for Health and Care Excellence (NICE) Clinical Guideline 154. Ectopic pregnancy and miscarriage. December 2012. Available from: http://guidance.nice.org.uk/cg154
- National Institute for Health and Care Excellence (NICE). Miscarriage Clinical Knowledge Summaries. July 2013. Available from: http://cks.nice.org.uk/miscarriage
- Saudi Society of Obstetrics and Gynecology Guidelines (SOGS). National Guidelines for prevention and treatment of miscarriages. Saudi J Obstet Gynecol 2014;15:40–63
- Coppola PT, Coppola M. Vaginal bleeding in the first 20 weeks of pregnancy. Emerg Med Clin North Am 2003;21:667–77
- Schindler AE. First trimester endocrinology: consequences for diagnosis and treatment of pregnancy failure. Gynecol Endocrinol 2004;18:51–7
- Schindler AE. Progestogens for treatment and pregnancy disorders. Horm Mol Biol Clin Invest 2010;3:453–460
- Macklon NS, Geraedts JP, Fauser BC. Conception to ongoing pregnancy: the ‘black box' of early pregnancy loss. Hum Reprod Update 2002;8:333–43
- Everett C. Incidence and outcome of bleeding before the 20th week of pregnancy: prospective study from general practice. BMJ 1997;351:32–4
- Blois SM, Joachim R, Kandil J, et al. Debletion of CD8+Cells abolishes the pregnancy protective effect of progesterone substitution with dydrogesterone in mice by altering the Th1/Th2 profile. J Immunology 2004;172:5893–9
- Wahabi HA, Abed Althagafi NF, Elawad M. Progestogen for treating threatened miscarriage. Cochrane Database Syst Rev 2007;18:CD005943
- Wahabi HA, Fayed AA, Esmaeil SA, Al Zeidan RA. Progestogen for treating threatened miscarriage. Cochrane Database Syst Rev 2011;12:CD005943
- Gerhard I, Gwinner B, Eggert-Kruse W, Runnebaum B. Double-blind controlled trial of progesterone substitution in threatened abortion. Bio Res Preg Perinatol 1987;8:26–34
- Palagiano A, Bulletti C, Pace MC, et al. Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Ann NY Acad Sci 2004;1034:200–10
- El-Zibdeh MY, Yousef LT. Dydrogesterone support in threatened miscarriage. Maturitas 2009;65:S43–6
- Pandian RU. Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas 2009;65:S47–50
- Carp H. A systematic review of dydrogesterone for the treatment of threatened miscarriage. Gynecol Endocrinol 2012;28:983–90
- Haas DM, Ramsey PS. Progestogen for preventing miscarriage. Cochrane Database Syst Rev 2013;10:CD003511
- El-Zibdeh MY. Dydrogesterone in the reduction of recurrent spontaneous abortion. J Steroid Biochem Mol Biol 2005;97:431–4
- MacDonald RR, Goulden R, Oakey RE. Cervical mucus, vaginal cytology and steroid excretion in recurrent abortion. Obstet Gynecol 1972;40:394–402
- Kumar A, Begum N, Prasad S, et al. Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double-blind, randomized, parallel, placebo-controlled trial. Fertil Steril 2014;102:1357–1363